Stockscreener 앱 받기
1.035
10.41%
-0.125
전일 마감가:
$1.16
열려 있는:
$1.16
하루 거래량:
1.59M
Relative Volume:
0.12
시가총액:
$123.80M
수익:
-
순이익/손실:
$-225.14M
주가수익비율:
-0.5281
EPS:
-1.96
순현금흐름:
$-192.27M
1주 성능:
-16.19%
1개월 성능:
-1.96%
6개월 성능:
+22.00%
1년 성능:
-74.47%
1일 변동 폭
$1.00
$1.16
1주일 범위
$1.00
$1.41
52주 변동 폭
$0.3546
$4.74
Invivyd Inc Stock (IVVD) Company Profile
명칭
Invivyd Inc
전화
(781) 819-0080
주소
1601 TRAPELO ROAD, WALTHAM
IVVD을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IVVD
Invivyd Inc
|
1.035 | 123.80M | 0 | -225.14M | -192.27M | -1.96 |
|
VRTX
Vertex Pharmaceuticals Inc
|
488.99 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
690.05 | 75.07B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
637.13 | 37.96B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
244.69 | 31.79B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
113.22 | 27.34B | 3.30B | -501.07M | 1.03B | -2.1146 |
Invivyd Inc Stock (IVVD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-04-05 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2024-03-26 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2023-12-19 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2023-05-01 | 개시 | H.C. Wainwright | Buy |
Invivyd Inc 주식(IVVD)의 최신 뉴스
Why Invivyd, Inc. (IVVD) is Skyrocketing So Far in 2025 - Yahoo Finance
Why These 15 Biotech Stocks Are Skyrocketing So Far In 2025 - Insider Monkey
The Zacks Analyst Blog Highlights INVIVYD, 21Vianet, FuboTV, Noodles and Digital Turbine - Yahoo Finance
Invivyd (NASDAQ:IVVD) Receives “Buy” Rating from D. Boral Capital - Defense World
Invivyd (NASDAQ:IVVD) Given “Buy” Rating at HC Wainwright - Defense World
FDA declines Invivyd’s COVID-19 treatment EUA expansion By Investing.com - Investing.com Nigeria
IVVD Stock: More Upside For Invivyd Inc (NASDAQ: IVVD)? - Marketing Sentinel
FDA Rejects Invivyd's Request To Expand Emergency Authorization For Preventive COVID-19 Antibody For Immunocompromised Patients - Benzinga
Sector Update: Health Care Stocks Flat to Higher Pre-Bell Monday - TradingView
Invivyd says FDA declines request to expand existing EUA of PEMGARDA - TipRanks
Sector Update: Health Care - TradingView
5 Stocks That More Than Doubled Halfway Through Q1 - Zacks Investment Research
Invivyd's Request to Treat Covid-19 Patients With Pemgarda Rejected by US FDA -February 24, 2025 at 08:04 am EST - Marketscreener.com
FDA declines Invivyd’s COVID-19 treatment EUA expansion - Investing.com
FDA declines Invivyd's COVID-19 treatment EUA expansion By Investing.com - Investing.com South Africa
FDA Declined Invivyd's Request to Expand Existing Emergency Use Authorization of PEMGARDA™ (pemivibart) to Include Treatment of Mild-to-Moderate COVID-19 For Immunocompromised Persons Who Have No Alternative Therapeutic Options; No Chang - The Manila Times
Can PEMGARDA Still Succeed? FDA Blocks COVID Treatment Expansion but Keeps Prevention Approval - StockTitan
Invivyd news ‘disappointing’ but not in model, says H.C. Wainwright - TipRanks
Invivyd, Inc. (NASDAQ:IVVD) Short Interest Up 5.2% in January - Armenian Reporter
Why Invivyd, Inc. (IVVD) Is Soaring This Year So Far - MSN
10 Micro and Small-Cap Firms Drive Year-to-Date Gains - Insider Monkey
Invivyd, Inc. (NASDAQ:IVVD) Sees Significant Growth in Short Interest - MarketBeat
Invivyd Inc (NASDAQ: IVVD) Stock Forecast: Bearish Views Expect -505.1 Percent Drop In 2025 - Stocks Register
Holdings of Invivyd Inc (IVVD) are aligned with the stars - SETE News
How does IVVD’s price to cash per share ratio compare in the market? - US Post News
Stock Traders Purchase High Volume of Invivyd Call Options (NASDAQ:IVVD) - MarketBeat
IVVD’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle
Invivyd Inc’s (IVVD) Stock: A Week-by-Week Analysis - The News Heater
Invivyd to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference on February 12, 2025 - The Manila Times
FY2024 Earnings Estimate for Invivyd Issued By HC Wainwright - MarketBeat
HC Wainwright Reaffirms "Buy" Rating for Invivyd (NASDAQ:IVVD) - MarketBeat
Invivyd Inc [IVVD] stock for 46,098 USD was sold by MCGUIRE TERRANCE - Knox Daily
Exploring High Growth Tech Stocks in the United States - Simply Wall St
Following A 407.69% Weekly Incline, Is It Still A Buy For Invivyd Inc (NASDAQ: IVVD)? - Marketing Sentinel
HC Wainwright Issues Negative Estimate for Invivyd Earnings - Defense World
Top Small Cap Stocks Worth WatchingFebruary 03rd - MarketBeat
This Penny Stock Just Doubled on Clinical Trial Results. Analysts Think It Can Surge 266% From Here. - MSN
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Invivyd (IVVD) Stock Rises Following Strategic Partnership - Stocks Telegraph
Invivyd tweaks COVID prophylactic playbook, teaming with NFL coach Jim Harbaugh for awareness drive - FiercePharma
Invivyd (NASDAQ:IVVD) Earns “Buy” Rating from HC Wainwright - Defense World
Los Angeles Chargers coach Jim Harbaugh reminds people COVID isn’t a cold - MM+M Online
Brokers Offer Predictions for Invivyd FY2029 Earnings - Defense World
Invivyd Inc Reports Q4 2024 Revenue of $13.8 Million, Slightly B - GuruFocus.com
H.C. Wainwright maintains Buy rating on Invivyd stock at $10 target - MSN
(IVVD)Analyzing Invivyd's Short Interest - Benzinga
Invivyd Announces Partnership with Pro Football Coach Jim Harbaugh to Elevate Awareness and Ongoing Impact of COVID-19: Common, Not A Cold - The Manila Times
Football Legend Jim Harbaugh Joins Forces with Invivyd as COVID Deaths Surge: One American Lost Every 9 Minutes - StockTitan
Analysts’ Revisions Show Improving Sentiment For Invivyd Inc (NASDAQ: IVVD) - Stocks Register
D. Boral Capital Reiterates “Buy” Rating for Invivyd (NASDAQ:IVVD) - Defense World
I See The Bull Case For Invivyd, But I’m Not Married To It (NASDAQ:IVVD) - Seeking Alpha
Invivyd Inc (IVVD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Invivyd Inc 주식 (IVVD) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| MCGUIRE TERRANCE | Director |
Dec 27 '24 |
Sale |
0.52 |
83,744 |
43,647 |
3,256,776 |
| MCGUIRE TERRANCE | Director |
Dec 30 '24 |
Sale |
0.48 |
86,545 |
41,784 |
3,170,231 |
| MCGUIRE TERRANCE | Director |
Dec 20 '24 |
Sale |
0.42 |
119,805 |
50,725 |
3,568,274 |
| MCGUIRE TERRANCE | Director |
Dec 26 '24 |
Sale |
0.54 |
83,817 |
45,563 |
3,340,520 |
| MCGUIRE TERRANCE | Director |
Dec 24 '24 |
Sale |
0.51 |
68,161 |
34,503 |
3,424,337 |
| MCGUIRE TERRANCE | Director |
Dec 23 '24 |
Sale |
0.45 |
75,776 |
34,076 |
3,492,498 |
2.96%
1.65%
자본화:
|
볼륨(24시간):